조절 인공수정체의 임상성적

Clinical Results of Crystalens; (AT-45) Accommodating Intraocular Lens

Purpose: To evaluate one-year clinical results of Crystalens<sup>&#9415; (AT-45, Eyeonics, CA, USA) accommodating IOL implantation. Methods: In this retrospective study, 25 eyes of 18 patients had phacoemulsification and Crystalens<sup>&#9415; accommodating IOL implantation. Distance and near visual acuity (VA) during the 12-months were measured. Results: At two months, uncorrected distance visual acuity (VA) of 13 eyes (52.0%) and 21 eyes (84.0%) were 20/25 and 20/40 or better, respectively. At six months, 11 eyes (44.0%) and 21 eyes (84.0%) were 20/25 and 20/40 or better, respectively. At 12 months, 11 eyes (44.0%) and 17 eyes (68.0%) were 20/25 and 20/40 or better, respectively. At two months, the uncorrected near VAs of 11 eyes (44.0%) and 17 eyes (68.0%) were 20/25 and 20/40 or better, respectively. At six months, 9 eyes (36.0%) and 16 eyes (64.0%) were 20/25 and 20/40 or better, respectively. After 12 months, 6 eyes (24.0%) and 16 eyes (64.0%) were 20/25 and 20/40 or better, respectively. Conclusions: The uncorrected near VAs gradually decreased with the passage of time until 12 months after Crystalens<sup>&#9415; accommodating IOL implantation.